Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Treatment interruptions news


From To
Community Recommendations for Clinical Research Involving Antiretroviral Treatment Interruptions in Adults

Scientists working to develop a cure for HIV infection sometimes need to conduct clinical trials in which participants are asked to temporarily interrupt ART, which contradicts the recommendations and guidelines for people with HIV under medical care.

15 November 2018
Antiretroviral shortage reaches 100% in Venezuela

Alberto Nieves, executive director of Acción Ciudadana Contra el SIDA (ACCSI) says: "By March 2018, the shortage of antiretroviral drugs reached 100% in Venezuela, which It is affecting more than 80 thousand people with HIV." Four of the 27 licensed antiretrovirals were still in stock but not ones necessary to construct viable combination therapy.

17 April 2018
Corresponsales Clave
Is It Ethical to Take People Off HIV Meds for Cure Research?

Cure studies typically require a temporary break in HIV treatment, often with little promise of a personal benefit to the participant.

13 September 2017
Fast Rebound After Treatment Interruption in 9 of 10 With Low HIV DNA Reservoir

Nine of 10 people with a cell-associated HIV DNA level below 100 copies/106 cells had an HIV RNA rebound within 12 weeks after antiretroviral therapy interruption. The 10th person maintained HIV RNA control without drugs for more than 48 weeks, according to a study published in AIDS.

13 June 2016
The Body PRO
Markers of Immune Exhaustion Predict Post-Treatment Control in HIV Patients

Biomarkers of immune exhaustion were associated with how long a patient was able to control HIV after treatment was interrupted, according to a study presented at CROI 2015.

05 March 2015
The Body
The Search for a Permanent Alternative to HIV Drugs

Researchers Carefully Tailor a Study to Find Patients to Test Going Off Antiretroviral Medication

16 February 2015
Wall Street Journal
Russia may face shortage of anti-AIDS drugs in 2015

Russia may face a shortage of anti-AIDS drugs in 2015 due to the current complex situation in the national economy and devaluation of the rouble, according to recent statements of Vadim Pokrovsky, head of the Russian Federal Research and Methodological Center for Prevention and Control of AIDS.

29 January 2015
ARV supply issues cause treatment interruptions in a UK clinic

We have been told of ARV stock-outs that resulted in patients having to interrupt HIV medication due to problems in drug supply. It is difficult to understand why a UK clinic would allow problems to develop to the point that this happened not just once, but several times.

01 December 2014
HIV i-Base
Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study

Our results show that early and prolonged cART may allow some individuals with a rather unfavorable background to achieve long-term infection control and may have important implications in the search for a functional HIV cure.

15 March 2013
PLoS Pathogens
Malawi: Malawi's Never-Ending Drug Shortage Problem

Malawi is again experiencing a crisis in the delivery of essential medicines, with understaffed clinics and erratic drug supplies preventing many dangerously ill patients from accessing treatment.

20 February 2013
← First12Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.